Olaplex Holdings Inc header image

Olaplex Holdings Inc

OLPX

Equity

ISIN US6793691089 / Valor 113471584

NASDAQ (2024-11-21)
USD 2.00+9.89%

Olaplex Holdings Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Olaplex Holdings Inc is a science-enabled beauty company focused on improving the hair health of consumers through innovative technology. The company disrupted the professional hair care industry in 2014 by introducing bond building products that protect, strengthen, and rebuild broken bonds in the hair. With patent-protected ingredients that work on a molecular level to repair damage, Olaplex's award-winning products are distributed globally through various channels, including professional salons, specialty retailers, and direct-to-consumer platforms.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Net Sales Performance

Olaplex Holdings Inc. reported a 4.8% decrease in net sales for the second quarter of 2024, totaling $103.9 million compared to the same period in 2023. The decline was driven by a mixed performance across different sales channels, with Specialty Retail increasing by 22.4% to $36.4 million, while Professional and Direct-To-Consumer channels saw decreases of 18.4% and 11.5%, respectively.

Geographical Sales Insights

For the second quarter of 2024, Olaplex Holdings Inc. experienced a 7.3% increase in net sales within the United States. However, this growth was offset by a 15.1% decrease in international sales. This geographical disparity highlights the company's stronger performance in its domestic market compared to its international operations.

Net Income and Earnings Per Share

Olaplex Holdings Inc. saw a 6.1% decrease in net income for the second quarter of 2024 compared to the same period in 2023. Despite this, the company's diluted earnings per share (EPS) remained consistent at $0.01 for both quarters. Adjusted net income also decreased by 11.6%, with adjusted diluted EPS holding steady at $0.03.

Gross Profit and Margins

In the second quarter of 2024, Olaplex Holdings Inc. reported a gross profit of $72.4 million, down from $77.5 million in the same quarter of the previous year. The gross profit margin slightly decreased to 69.7% from 70.9%. Adjusted gross profit was $74.7 million, with an adjusted gross profit margin of 71.9%, reflecting a minor decline from the previous year's 72.7%.

Fiscal Year 2024 Guidance

Olaplex Holdings Inc. reiterated its fiscal year 2024 guidance, projecting net sales between $435 million and $463 million. The company also expects adjusted net income to range from $87 million to $100 million and adjusted EBITDA between $143 million and $159 million. This guidance reflects management's confidence in the company's long-term growth potential and strategic direction.

Summarized from source with an LLMView Source

Key figures

5.82%1Y
-92.9%3Y
%5Y

Performance

81.9%1Y
85.7%3Y
85.4%5Y

Volatility

Market cap

1342 M

Market cap (USD)

Daily traded volume (Shares)

760,998

Daily traded volume (Shares)

1 day high/low

2.015 / 1.82

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%GBP 2.17
KK Fancl
KK Fancl KK Fancl Valor: 960002
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%JPY 2,794.00
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.24%EUR 61.85
Quanterix Corporation
Quanterix Corporation Quanterix Corporation Valor: 39127916
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.35%USD 11.72
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. Nano-X Imaging Ltd. Valor: 56410599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.58%USD 6.16
ModivCare Inc
ModivCare Inc ModivCare Inc Valor: 59168951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.11%USD 17.47
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.26%USD 20.37
PACS Group Inc
PACS Group Inc PACS Group Inc Valor: 133777092
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.06%USD 16.55
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.93%USD 2.11
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 11.52